Clinical Trial Update: Genistein in Preventing Breast Cancer in Women at High Risk for Breast Cancer [Phase 2]

View source ↗

Summary

This update reports the completion of a Phase 2 trial evaluating genistein for breast cancer prevention in women at high risk, with results posted in 2017.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Drugs mentioned

• Genistein (genistein)

Snippet

Sponsor: National Cancer Institute (NCI) | Conditions: Breast Cancer | Phase 2 | Status: COMPLETED | Results posted: 2017-02-08